Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serotonin (5-HT) release is a complex process involving exocytotic (vesicular) and nonexocytotic mechanisms. Exocytosis, triggered by calcium influx, releases serotonin into the synaptic cleft. Nonexocytotic release involves diffusion of cytosolic serotonin across the plasma membrane. Somatic/extrasynaptic release, under high-frequency stimulation, results in prolonged signaling from cell bodies and dendrites. The Serotonin Transporter (SERT) and autoreceptors tightly regulate extracellular serotonin concentrations. This multifaceted mechanism enables fine-tuned spatial-temporal control over serotonergic signaling.
SSRIs block SERT to increase synaptic serotonin; MAOIs inhibit serotonin breakdown, increasing its availability.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Release Mechanism (N/A).